182 related articles for article (PubMed ID: 27233613)
1. miR-137 suppresses tumor growth of malignant melanoma by targeting aurora kinase A.
Chang X; Zhang H; Lian S; Zhu W
Biochem Biophys Res Commun; 2016 Jul; 475(3):251-6. PubMed ID: 27233613
[TBL] [Abstract][Full Text] [Related]
2. AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy.
Puig-Butille JA; Vinyals A; Ferreres JR; Aguilera P; Cabré E; Tell-Martí G; Marcoval J; Mateo F; Palomero L; Badenas C; Piulats JM; Malvehy J; Pujana MA; Puig S; Fabra À
J Invest Dermatol; 2017 Jun; 137(6):1297-1310. PubMed ID: 28188776
[TBL] [Abstract][Full Text] [Related]
3. miR-124 suppresses glioblastoma growth and potentiates chemosensitivity by inhibiting AURKA.
Qiao W; Guo B; Zhou H; Xu W; Chen Y; Liang Y; Dong B
Biochem Biophys Res Commun; 2017 Apr; 486(1):43-48. PubMed ID: 28242198
[TBL] [Abstract][Full Text] [Related]
4. MiR-154 inhibits cells proliferation and metastasis in melanoma by targeting AURKA and serves as a novel prognostic indicator.
Wang J; Fang Y; Liu YF; Wang X; Wang XL; Wang RY; Meng ZD
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4275-4284. PubMed ID: 31173299
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA.
Yuan Q; Sun T; Ye F; Kong W; Jin H
Cancer Biomark; 2017; 19(1):93-101. PubMed ID: 28269755
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Hedgehog signaling pathway suppresses cell proliferation by regulating the Gli2/miR-124/AURKA axis in human glioma cells.
Xu L; Liu H; Yan Z; Sun Z; Luo S; Lu Q
Int J Oncol; 2017 May; 50(5):1868-1878. PubMed ID: 28393219
[TBL] [Abstract][Full Text] [Related]
7. SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B.
Yu Z; Sun Y; She X; Wang Z; Chen S; Deng Z; Zhang Y; Liu Q; Liu Q; Zhao C; Li P; Liu C; Feng J; Fu H; Li G; Wu M
J Hematol Oncol; 2017 Jun; 10(1):115. PubMed ID: 28595628
[TBL] [Abstract][Full Text] [Related]
8. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
[TBL] [Abstract][Full Text] [Related]
9. Aurora kinase A mediates c-Myc's oncogenic effects in hepatocellular carcinoma.
Lu L; Han H; Tian Y; Li W; Zhang J; Feng M; Li Y
Mol Carcinog; 2015 Nov; 54(11):1467-79. PubMed ID: 25284017
[TBL] [Abstract][Full Text] [Related]
10. Linc00299/miR-490-3p/AURKA axis regulates cell growth and migration in atherosclerosis.
Liu Y; Chen Y; Tan L; Zhao H; Xiao N
Heart Vessels; 2019 Aug; 34(8):1370-1380. PubMed ID: 30734057
[TBL] [Abstract][Full Text] [Related]
11. MiR-769 promoted cell proliferation in human melanoma by suppressing GSK3B expression.
Qiu HJ; Lu XH; Yang SS; Weng CY; Zhang EK; Chen FC
Biomed Pharmacother; 2016 Aug; 82():117-23. PubMed ID: 27470346
[TBL] [Abstract][Full Text] [Related]
12. CDCA2 promotes melanoma progression by inhibiting ubiquitin-mediated degradation of Aurora kinase A.
Sun W; Jin Y; Wei C; Xu Y; Liu W; Zhong J; Zou Z; Lin X; Xiang Y; Chen Y
Eur J Cancer; 2023 Jul; 188():49-63. PubMed ID: 37196484
[TBL] [Abstract][Full Text] [Related]
13. MiRNA-621 exerts tumor suppressor function in gastric adenocarcinoma by targeting AURKA/GSK-3β pathway.
Han X; Liu H; Tang X; Zhao Y
Acta Biochim Pol; 2021 Feb; 68(1):91-98. PubMed ID: 33629578
[TBL] [Abstract][Full Text] [Related]
14. Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells.
Katsha A; Wang L; Arras J; Omar OM; Ecsedy J; Belkhiri A; El-Rifai W
Clin Cancer Res; 2017 Jul; 23(14):3756-3768. PubMed ID: 28073841
[No Abstract] [Full Text] [Related]
15. MiR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1.
Chang X; Sun Y; Han S; Zhu W; Zhang H; Lian S
Biochem Biophys Res Commun; 2015 Jan; 456(1):361-6. PubMed ID: 25475727
[TBL] [Abstract][Full Text] [Related]
16. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
Lohcharoenkal W; Das Mahapatra K; Pasquali L; Crudden C; Kular L; Akkaya Ulum YZ; Zhang L; Xu Landén N; Girnita L; Jagodic M; Ståhle M; Sonkoly E; Pivarcsi A
J Invest Dermatol; 2018 Apr; 138(4):882-892. PubMed ID: 29104160
[TBL] [Abstract][Full Text] [Related]
17. Targeting of TRX2 by miR-330-3p in melanoma inhibits proliferation.
Yao Y; Zuo J; Wei Y
Biomed Pharmacother; 2018 Nov; 107():1020-1029. PubMed ID: 30257313
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-148b Inhibits the Malignant Biological Behavior of Melanoma by Reducing Sirtuin 7 Expression Levels.
Sun R; Guo M; Fan X; Meng Q; Yuan D; Yang X; Yan K; Deng H
Biomed Res Int; 2020; 2020():9568976. PubMed ID: 33274232
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW; Bosserhoff AK
Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
[TBL] [Abstract][Full Text] [Related]
20. Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells.
Pathria G; Garg B; Borgdorff V; Garg K; Wagner C; Superti-Furga G; Wagner SN
Cell Death Dis; 2016 Mar; 7(3):e2135. PubMed ID: 26962685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
